Clinical Trial Update: A Study of How Insulin Peglispro (LY2605541) and Insulin Glargine Affect the Breakdown of Fat and Sugar in Type 1 Diabetics [Phase 1]

View source ↗

Summary

A Phase 1 trial comparing insulin peglispro and insulin glargine in adults with Type 1 diabetes to assess effects on fat and sugar metabolism; completed with po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine (insulin glargine)
• insulin peglispro (LY2605541) (insulin peglispro)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Type 1 Diabetes Mellitus | Phase 1 | Status: COMPLETED | Results posted: 2019-03-01